These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31616136)

  • 1. Comparing quality of life and treatment satisfaction between patients on warfarin and direct oral anticoagulants: a cross-sectional study.
    Ng DL; Gan GG; Chai CS; Chee KH; Tan KL; Tan SB; Bee PC
    Patient Prefer Adherence; 2019; 13():1363-1373. PubMed ID: 31616136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism.
    Fang MC; Go AS; Prasad PA; Zhou HX; Parks AL; Fan D; Portugal C; Sung SH; Reynolds K
    Thromb Res; 2022 Aug; 216():97-102. PubMed ID: 35779378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Veterans Perceptions of Satisfaction and Convenience with Anticoagulants for Atrial Fibrillation: Warfarin versus Direct Oral Anticoagulants.
    Mull HJ; Shin MH; Engle RL; Linsky AM; Kalver E; Lamkin R; Sullivan JL
    Patient Prefer Adherence; 2020; 14():1911-1922. PubMed ID: 33116435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study.
    Ng DL; Malik NMBA; Chai CS; Goh GM; Tan SB; Bee PC; Gan GG; Said AB
    Health Qual Life Outcomes; 2020 Oct; 18(1):347. PubMed ID: 33081816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation.
    Benzimra M; Bonnamour B; Duracinsky M; Lalanne C; Aubert JP; Chassany O; Aubin-Auger I; Mahé I
    Patient Prefer Adherence; 2018; 12():79-87. PubMed ID: 29379275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation and CKD G3-G5D.
    Welander F; Renlund H; Dimény E; Holmberg H; Själander A
    Clin Kidney J; 2023 May; 16(5):835-844. PubMed ID: 37151425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Retrospective Review of Upper Gastrointestinal Bleed Outcomes During Hospital Admission While on Oral Anticoagulation.
    Scibelli N; Mangano A; Raynor K; Wilson S; Singh P
    Cureus; 2021 May; 13(5):e15061. PubMed ID: 34150404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and discharge patterns among patients hospitalized with non-valvular atrial fibrillation transitioning from the inpatient to outpatient setting.
    Henk HJ; Cao F; Tuell K; Price K; Singh P; Mardekian J; Odell K; Patel C; Tan W; Sands GH; Singhal S; Trocio J; Vo L
    Curr Med Res Opin; 2018 Mar; 34(3):539-546. PubMed ID: 29235900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of Gastrointestinal Bleeding in Patients Treated with Direct-Acting Oral Anticoagulants.
    Brodie MM; Newman JC; Smith T; Rockey DC
    Am J Med; 2018 May; 131(5):573.e9-573.e15. PubMed ID: 29175237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life after switching from well-controlled vitamin K antagonist to direct oral anticoagulant: Little to GAInN.
    van Miert JHA; Kooistra HAM; Veeger NJGM; Westerterp A; Piersma-Wichers M; Meijer K
    Thromb Res; 2020 Jun; 190():69-75. PubMed ID: 32315869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OC-13 - Safe and effective use of direct oral anticoagulants (DOAC) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism.
    Ross JA; Miller M; Hernandez CR
    Thromb Res; 2016 Apr; 140 Suppl 1():S173-4. PubMed ID: 27161685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient Satisfaction with Direct Oral Anticoagulants and Warfarin.
    Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Arima K; Kotani T; Nomoto K; Ikeya Y; Fukushima S; Onikura M; Suzuki Y; Fujita M; Ando H; Ishikawa N; Hirayama A;
    Int Heart J; 2018 Nov; 59(6):1266-1274. PubMed ID: 30369576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
    Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism.
    Keita I; Aubin-Auger I; Lalanne C; Aubert JP; Chassany O; Duracinsky M; Mahé I
    Patient Prefer Adherence; 2017; 11():1625-1634. PubMed ID: 29026288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.
    Hendriks T; McGregor S; Rakesh S; Robinson J; Ho KM; Baker R
    PLoS One; 2020; 15(6):e0234048. PubMed ID: 32497116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High number of newly initiated direct oral anticoagulant users switch to alternate anticoagulant therapy.
    Manzoor BS; Walton SM; Sharp LK; Galanter WL; Lee TA; Nutescu EA
    J Thromb Thrombolysis; 2017 Nov; 44(4):435-441. PubMed ID: 29027097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation.
    Brais C; Larochelle J; Turgeon MH; Blais L; Farand P; Perreault S; Letemplier G; Beauchesne MF
    J Pharm Pharm Sci; 2017; 20():8-14. PubMed ID: 28459661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Direct Oral Anticoagulants on Quality of Life During Periprocedural Management for Dental Extractions.
    Cabbar F; Cabbar AT; Coşansu K; Çekirdekçi Eİ
    J Oral Maxillofac Surg; 2019 May; 77(5):904-911. PubMed ID: 30611688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal versus genotype-guided use of direct oral anticoagulants in atrial fibrillation patients: a decision analysis.
    You JH
    Pharmacogenomics; 2015; 16(10):1089-100. PubMed ID: 26230572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding Risk of Warfarin and Direct Oral Anticoagulants in Younger Population: A Historical Cohort Study Using a Japanese Claims Database.
    Yokoyama S; Tanaka Y; Nakagita K; Hosomi K; Takada M
    Int J Med Sci; 2018; 15(14):1686-1693. PubMed ID: 30588192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.